Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
$31.66
$8.62
$58.94
$73.49M2.1532,471 shs77 shs
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
$22.89
+0.0%
$23.68
$21.58
$31.49
$406.30M0.9984,209 shs48,490 shs
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
$0.42
-1.0%
$0.51
$0.26
$3.28
$12.34M3.451.09 million shs255,964 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
0.00%0.00%0.00%0.00%0.00%
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
-8.63%-0.26%-2.26%-19.66%-12.30%
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
-2.10%+8.92%-9.01%-35.36%-82.93%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
N/AN/AN/AN/AN/AN/AN/AN/A
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
3.9835 of 5 stars
3.32.01.70.01.62.53.8
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
3.00
Buy$3,400.00∞ Upside
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
2.50
Moderate Buy$30.5033.25% Upside
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
N/AN/AN/AN/A

Current Analyst Ratings

Latest CSU, PGC, RDHL, and MDG1 Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral
4/5/2024
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$33.50 ➝ $30.50
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
$383.86M0.00N/AN/A($131.19) per share0.00
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
$377.59M1.08$3.47 per share6.59$32.76 per share0.70
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
$6.53M1.89$1.30 per share0.32$0.11 per share3.78

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
-$295.37M$49.780.67N/AN/A40.40%N/A-5.64%N/A
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
$48.85M$2.1810.507.95N/A10.11%7.27%0.64%7/23/2024 (Estimated)
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
$23.92MN/A0.00N/AN/AN/AN/A6/10/2024 (Estimated)

Latest CSU, PGC, RDHL, and MDG1 Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
1/25/2024Q4 2023
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
$0.56$0.50-$0.06$0.52$54.91 million$54.27 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
N/AN/AN/AN/AN/A
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
$0.200.87%N/A9.17%N/A
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
N/A
0.11
0.11
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
0.23
0.98
0.98
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
N/A
0.84
0.61

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
62.65%
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
72.75%
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
7.20%

Insider Ownership

CompanyInsider Ownership
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
5.46%
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
7.63%
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
6.81%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
3,4162.19 million2.07 millionOptionable
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
52117.75 million16.40 millionOptionable
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
11329.70 million27.68 millionNo Data

CSU, PGC, RDHL, and MDG1 Headlines

SourceHeadline
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 StudyRedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
finance.yahoo.com - April 24 at 11:40 AM
RedHill Biopharma (NASDAQ:RDHL) Now Covered by StockNews.comRedHill Biopharma (NASDAQ:RDHL) Now Covered by StockNews.com
americanbankingnews.com - April 18 at 2:30 AM
RedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (vs US$46.29 loss in FY 2022)RedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (vs US$46.29 loss in FY 2022)
finance.yahoo.com - April 10 at 10:40 AM
Raleigh pharma weighs divesting commercial operationsRaleigh pharma weighs divesting commercial operations
bizjournals.com - April 9 at 1:31 PM
RedHill Biopharma Ltd.: RedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsRedHill Biopharma Ltd.: RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
finanznachrichten.de - April 8 at 4:40 PM
RedHill Biopharma Ltd. (2RH0.F)RedHill Biopharma Ltd. (2RH0.F)
finance.yahoo.com - April 8 at 4:40 PM
RedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsRedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
prnewswire.com - April 8 at 9:23 AM
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market PriceRedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
finance.yahoo.com - April 2 at 10:24 AM
RedHill announces new ten-year patent for TaliciaRedHill announces new ten-year patent for Talicia
thepharmaletter.com - March 11 at 12:39 PM
RedHill Biopharma Receives New Patent For H. Pylori Treatment TaliciaRedHill Biopharma Receives New Patent For H. Pylori Treatment Talicia
markets.businessinsider.com - March 11 at 12:39 PM
RedHill Announces New USPTO Patent Covering Talicia® Through 2034RedHill Announces New USPTO Patent Covering Talicia® Through 2034
finance.yahoo.com - March 11 at 7:36 AM
RedHills Opaganib Selected for Evaluation by BARDA and NIH Countermeasures ProgramsRedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs
finance.yahoo.com - March 5 at 9:11 AM
RedHills Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New PublicationRedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication
finance.yahoo.com - February 20 at 9:23 AM
RedHills Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New PublicationRedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication
prnewswire.com - February 20 at 7:00 AM
RedHill Biopharma Ltd. ADRRedHill Biopharma Ltd. ADR
barrons.com - February 16 at 7:57 AM
RedHill Biopharma Announces Closing of $8 Million Registered Direct OfferingRedHill Biopharma Announces Closing of $8 Million Registered Direct Offering
finance.yahoo.com - January 26 at 8:38 PM
RedHill gains after new patent grant for Talicia for H. pylori treatment through 2042RedHill gains after new patent grant for Talicia for H. pylori treatment through 2042
msn.com - January 25 at 9:37 AM
RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042
finance.yahoo.com - January 25 at 9:37 AM
RedHill Biopharma Announces $8 Million Registered Direct OfferingRedHill Biopharma Announces $8 Million Registered Direct Offering
finance.yahoo.com - January 25 at 9:37 AM
Why Redhill Biopharma Stock Is Moving HigherWhy Redhill Biopharma Stock Is Moving Higher
benzinga.com - January 24 at 12:27 PM
RedHills Investigational COVID-19 Drugs Combined With Gileads Show Effect Against EbolaRedHill's Investigational COVID-19 Drugs Combined With Gilead's Show Effect Against Ebola
msn.com - December 20 at 6:33 PM
RedHill Announces Results Of A New U.S. Army-funded In Vivo Ebola Virus StudyRedHill Announces Results Of A New U.S. Army-funded In Vivo Ebola Virus Study
markets.businessinsider.com - December 20 at 1:32 PM
RedHill shares rally 20% on positive data for two antiviral drugsRedHill shares rally 20% on positive data for two antiviral drugs
msn.com - December 20 at 1:32 PM
RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against EbolaRedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola
finance.yahoo.com - December 20 at 1:32 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Capital Senior Living logo

Capital Senior Living

NYSE:CSU
Capital Senior Living Corp. engages in the operation of senior housing communities. Its senior living options include independent living, assisted living, and memory care. The company was founded in 1990 and is headquartered in Dallas, TX.
Peapack-Gladstone Financial logo

Peapack-Gladstone Financial

NASDAQ:PGC
Peapack-Gladstone Financial Corporation operates as the bank holding company for Peapack-Gladstone Bank that provides private banking and wealth management services in the United States. The company operates in two segments, Banking and Peapack Private. It offers checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, and individual retirement accounts. The company also provides working capital lines of credit, term loans for fixed asset acquisitions, commercial mortgages, multi-family mortgages, and other forms of asset-based financing services; and residential mortgages, home equity lines of credit, and other second mortgage loans. In addition, it offers corporate and industrial (C&I) and equipment finance, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; C&I advisory services; escrow management; deposit generation; investment management services; personal trust services, including services as executor, trustee, administrator, custodian, and guardian; and other financial planning, tax preparation, and advisory services. Further, the company provides telephone and Internet banking, merchant credit card, and customer support sales services. Its private banking clients include businesses, non-profits, and consumers; wealth management clients comprise individuals, families, foundations, endowments, trusts, and estates; and commercial loan clients include business owners, professionals, retailers, contractors, and real estate investors. The company operates its private banking locations in Bedminster, Morristown, Princeton, and Teaneck, New Jersey; and branches in Somerset, Morris, Hunterdon, and Union counties, as well as operates automated teller machines. Peapack-Gladstone Financial Corporation was founded in 1921 and is headquartered in Bedminster, New Jersey.
RedHill Biopharma logo

RedHill Biopharma

NASDAQ:RDHL
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; and RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.